3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Phase 2
1
Status
Not yet recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Colorectal Neoplasms
74
Colonic Neoplasms
31
Rectal Neoplasms
29
Neoplasm Metastasis
16
Stomach Neoplasms
12
Pancreatic Neoplasms
12
Esophageal Squamous Cell Carcinoma
8
Small Cell Lung Carcinoma
7
Neoplasms
6
Esophageal Neoplasms
6
Rhabdomyosarcoma
4
Intestinal Neoplasms
4
Gastrointestinal Neoplasms
4
Digestive System Neoplasms
4
Uterine Cervical Neoplasms
3
Sarcoma
3
Parkinson Disease 4, Autosomal Dominant Lewy Body
3
Cholangiocarcinoma
3
Biliary Tract Neoplasms
3
Rectal Diseases
2
Neuroblastoma
2
Neoplasms by Histologic Type
2
Intestinal Diseases
2
Hepatoblastoma
2
Gastrointestinal Diseases
2
Ganglioneuroblastoma
2
Digestive System Diseases
2
Colorectal Cancer Metastatic
2
Colorectal Adenocarcinoma
2
Colonic Diseases
2
Interventions
Cyclophosphamide
3
Epirubicin
2
Docetaxel
2
Carboplatin
2
Capecitabine
2
Azacitidine
2
venetoclax
1
tegafur-gimeracil-oteracil
1
taxane
1
sargramostim
1
ruxolitinib
1
rucaparib
1
pirarubicin
1
pertuzumab
1
pembrolizumab
1
olaparib
1
cc-486
1
Trastuzumab
1
Thalidomide
1
Radiotherapy
1
Radiation
1
Platinum
1
Paclitaxel
1
Oxaliplatin
1
Observation
1
Nivolumab
1
Monatide (IMS 3015)
1
Methotrexate
1
Magnetic Resonance Imaging
1
Leucovorin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 3
×
Pathologic Complete Response
×
Irinotecan
×
Clear all
NCT07472868
2026-03-16
MEND-IT II
Catharina Ziekenhuis Eindhoven
Phase 3
Not yet recruiting
394 enrolled